Patients with hemophilia have a higher risk of bleeding in the vitreous gel of the eye after vitrectomy surgery. However, ophthalmologists can minimize the risk of bleeding in hemophiliacs by giving the patient clotting treatments, state the National Center for Biotechnology Information.
A vitrectomy, the procedure that removes the vitreous gel from the center of the eye, is a surgery that ophthalmologists conduct during retinal detachment or bleeding in the eye. Vitrectomies repair retinal detachment and tears in the retina. Patients with hemophilia in particular may need a vitrectomy if they have hemorrhaging as well as retinal detachment.
If retinal detachment does not affect the macula and central vision, then a vitrectomy can greatly improve vision, WebMD says. However, one side effect that hemophilia patients may experience is further bleeding into the vitreous gel, which can threaten vision and reverse the beneficial effects of the surgery. Doctors use clotting agents to prevent bleeding in hemophiliacs so that eye surgeries work just as well for them as for other patients, the National Center for Biotechnology Information claims.
Typically, a vitrectomy can repair retinal detachment. In some cases, however, patients need to undergo multiple procedures to repair the retina fully, WebMD says. Those with hemophilia may continue to receive extra treatment for their condition after undergoing eye surgery.